Mark Christopher Capone
CIK 1352413 · President & C.E.O. · last filed 2026-03-10
Mark Christopher Capone is a President & C.E.O. who has filed 56 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider bought $99.3K of MLAB on Mar 10, 2026. Across all open-market trades the lifetime net is −$30.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.62M
3
56
-$30.69M
Holdings By Company
Recent Filings
56 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-10 | MLAB | Buy (P) | +1,301 | $99.3K | EDGAR |
| 2025-08-18 | MLAB | Mixed | +1,404 | $0 | EDGAR |
| 2024-08-19 | MLAB | Mixed | +724 | $0 | EDGAR |
| 2024-02-16 | MLAB | Grant (A) | — | $0 | EDGAR |
| 2023-06-05 | DermTech, Inc. (DMTK) Delisted | Grant (A) | +35,714 | $0 | EDGAR |
| 2022-07-20 | DermTech, Inc. (DMTK) Delisted | Grant (A) | +46,340 | $0 | EDGAR |
| 2019-10-01 | MYGN | Disp (D) | −27,022 | -$773.6K | EDGAR |
| 2019-09-26 | MYGN | Mixed | +108,405 | -$1.02M | EDGAR |
| 2019-08-02 | MYGN | Mixed | — | -$2.41M | EDGAR |
| 2018-10-02 | MYGN | Disp (D) | −27,022 | -$1.24M | EDGAR |